Method Article

Dose Uptake of Platinum- and Ruthenium-based Compound Exposure in Zebrafish by Inductively Coupled Plasma Mass Spectrometry with Broader Applications

DOI:

10.3791/63587

⸱

April 21st, 2022

 ,  ,  ,  ,  , 
1Environmental and Occupational Health Sciences Institute, Rutgers University, 2Department of Biochemistry and Microbiology, Rutgers University, 3Centro de Química Estrutural and Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa

In This Article

Summary

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The increased rate of pharmaco- and toxicokinetic analyses of metals and metal-based compounds in zebrafish can be advantageous for environmental and clinical translation studies. The limitation of unknown waterborne exposure uptake was overcome by conducting trace metal analysis on digested zebrafish tissue using inductively coupled plasma mass spectrometry.

Abstract

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Metals and metal-based compounds comprise multifarious pharmaco-active and toxicological xenobiotics. From heavy metal toxicity to chemotherapeutics, the toxicokinetics of these compounds have both historical and modern-day relevance. Zebrafish have become an attractive model organism in elucidating pharmaco- and toxicokinetics in environmental exposure and clinical translation studies. Although zebrafish studies have the benefit of being higher-throughput than rodent models, there are several significant constraints to the model.

One such limitation is inherent in the waterborne dosing regimen. Water concentrations from these studies cannot be extrapolated to provide reliable internal dosages. Direct measurements of the metal-based compounds allow for a better correlation with compound-related molecular and biological responses. To overcome this limitation for metals and metal-based compounds, a technique was developed to digest zebrafish larval tissue after exposure and quantify metal concentrations within tissue samples by inductively coupled plasma mass spectrometry (ICPMS).

ICPMS methods were used to determine the metal concentrations of platinum (Pt) from cisplatin and ruthenium (Ru) from several novel Ru-based chemotherapeutics in zebrafish tissue. Additionally, this protocol distinguished concentrations of Pt that were sequestered in the chorion of the larval compared with the zebrafish tissue. These results indicate that this method can be applied to quantitate the metal dose present in larval tissues. Further, this method may be adjusted to identify specific metals or metal-based compounds in a broad range of exposure and dosing studies.

Introduction

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Metals and metal-based compounds continue to have pharmacological and toxicological relevance. The prevalence of heavy metal exposure and its impact on health has exponentially increased scientific investigation since the 1960s and reached an all-time high in 2021. The concentrations of heavy metals in drinking water, air pollution, and occupational exposure exceeds regulatory limits worldwide and remain an issue for arsenic, cadmium, mercury, chromium, lead, and other metals. Novel methods to quantify environmental exposure and analyze pathological development continue to be in high demand1,2,3.

Conversely, the medical field has harnessed the physiochemical properties of various metals for clinical treatment. Metal-based drugs or metallodrugs have a rich history of medicinal purposes and have shown activity against a range of diseases, with the highest success as chemotherapeutics4. The most famous of metallodrugs, cisplatin, is a Pt-based anticancer drug deemed by the World Health Organization (WHO) as one of the world's essential drugs5. In 2010, cisplatin and its Pt derivatives had up to a 90% success rate in several cancers and were used in approximately 50% of chemotherapy regimens6,7,8. Although Pt-based chemotherapeutics have had irrefutable success, the dose-limiting toxicity has set in motion investigations of alternative metal-based drugs with refined biological delivery and activity. Of these alternatives, Ru-based compounds have become the most popular9,10,11,12.

Novel models and methodology are required to keep pace with the rate of need for metal pharmaco- and toxicokinetic studies. The zebrafish model lies at the intersection of complexity and throughput, being a high-fecundity vertebrate with 70% conserved gene homology13. This model has been an asset in pharmacology and toxicology, with extensive screenings for various compounds for lead discovery, target identification, and mechanistic activity14,15,16,17. However, high-throughput screening of chemicals typically relies on waterborne exposures. Given that uptake can be variable based on the physicochemical properties of the compound in solution (i.e., photodegradation, solubility), this can be a major limitation of correlating dose delivery and response.

To overcome this limitation for comparison of dose to higher vertebrates, a methodology was designed to analyze trace metal concentrations in zebrafish larval tissue. Here, dose-response curves of lethal and sublethal endpoints were evaluated for cisplatin and novel Ru-based anticancer compounds. Lethality and delayed hatching were evaluated for nominal concentrations of 0, 3.75, 7.5, 15, 30, and 60 mg/L cisplatin. Pt accumulation in organism tissue was determined by ICPMS analysis, and organism uptake of respective doses were 0.05, 8.7, 23.5, 59.9, 193.2, and 461.9 ng (Pt) per organism. Additionally, zebrafish larvae were exposed to 0, 3.1, 6.2, 9.2, 12.4 mg/L of PMC79. These concentrations were analytically determined to contain 0, 0.17, 0.44, 0.66, and 0.76 mg/L of Ru. This protocol also allowed for the distinguishment of concentrations of Pt sequestered in the chorion of the larvae compared with the zebrafish tissue. This methodology was able to provide reliable, robust data for comparisons of pharmaco- and toxicokinetic activity between a well-established chemotherapeutic and a novel compound. This method can be applied to a wide range of metals and metal-based compounds.

Access restricted. Please log in or start a trial to view this content.

Protocol

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The AB strain zebrafish (Danio rerio) were used for all experiments (see the Table of Materials), and the husbandry protocol (#08-025) was approved by the Rutgers University Animal Care and Facilities Committee.

1. Zebrafish husbandry

  1. Breed and maintain the zebrafish in a recirculating aquatic habitat system on a 14 h light:10 h dark cycle.
    1. Purify municipal tap water through sand and carbon filtration to obtain fish system water. Maintain the aquatic system water at 28 °C, <0.05 ppm nitrite, <0.2 ppm ammonia, and pH between 7.2 and 7.7.
    2. Feed the zebrafish a diet of hatched Artemia cysts, brine shrimp, and fish diet flake food.

2. Zebrafish dose-response protocol (Figure 1)

  1. Prepare zebrafish egg water solution, either E3 medium or egg water made from stock sea salt at a concentration of 60 µg/mL dissolved in deionized water18. Avoid the use of methylene blue.
    NOTE: Through ICPMS, isobaric interference of zebrafish egg water was identified for strontium oxides, which overlapped with an isotope of ruthenium. Careful rinsing of the larvae before downstream analysis ameliorated this issue. E3 medium may be an easier choice for some due to the proprietary makeup of commercial sea salts.
  2. Dissolve the metal or metal-based compounds in E3 or egg water. Vortex to break up any aggregate material and homogenize the solution.
    NOTE: In the experiment outlined below, PMC79 and cisplatin were dissolved at maximum concentrations of 12.4 mg/L and 60 mg/L with a maximum concentration of 0.5% dimethyl sulfoxide (DMSO) to resist precipitation.
    1. Dilute heavy metal or metal-based compounds, such as PMC79 and cisplatin, with E3 or egg water, preparing at least 5 concentration doses.
      1. Begin with low concentrations of stock solutions in pure vehicle (i.e., DMSO), then dilute with E3 or egg water. Consider the final vehicle concentrations carefully.
        NOTE: Certain metal-based compounds, such as cisplatin, degrade rapidly, and their solutions must be made fresh daily. CAUTION: Handle heavy metals and chemotherapeutics with care. Review the specific material safety data sheet (MSDS) for the metal of interest. Cisplatin may cause eye and skin irritation, be fatal if swallowed, and can cause toxicity in kidneys, blood, blood-forming organs, and fetal tissue. Avoid breathing fumes and contact with eyes, skin, and clothing. Wear impervious gloves and clothing, and safety glasses or goggles19.
  3. Set up breeding tanks the afternoon prior to the experiment in the ideal ratio of 2 females to 1 male with a divider in place between the sexes20.
    1. Pull the divider when the lights come on for the morning cycle.
    2. Allow the zebrafish to breed.
      NOTE: The length of time for breeding depends on the initial exposure stage required. For 3 h postfertilization, allow breeding for approximately 2 h. The eggs will reach 3 hpf after cleaning and segregating eggs.
    3. Move the breeding fish to a clean tank.
    4. Collect the eggs by pouring the tank water through a strainer.
    5. Invert the strainer over a Petri dish and use a squirt bottle filled with E3 or egg water to rinse the eggs into the dish.
    6. Clean the dish of food and waste prior to experimental use.
  4. Randomize approximately twenty 3 hpf embryos per dose into individual glass vials using a transfer pipette and a small quantity of water.
  5. After all embryos are in vials, remove all egg water and replace with enough dosing solution so that there is approximately 1 inch of solution above the height of the egg.
    NOTE: The necessity of dechorionation should be carefully considered. See the discussion section for more details.
  6. Observe the embryos daily for lesions or lethality. Due to the rapid development of embryonic zebrafish, obtain daily images using any brightfield microscope/camera setup to identify minor lesions between days.
  7. At the termination of the dose response (4-5 days post fertilization [dpf], per Organization Economic Cooperation and Development [OECD] guideline21), combine 3-5 larvae prior to euthanization for composite sampling. Euthanize by rapid cooling by snap-freezing in liquid nitrogen.
    NOTE: Euthanasia through an overdose of MS-222 or tricaine methanesulfonate may potentially interfere with ICPMS analysis downstream. Rapid-cooling euthanasia methods are encouraged for this protocol to reduce the possibility of interference.
  8. Conduct 3 washes of tissue with high-purity water (such as reverse osmosis) to remove the excess compound from the exterior of the tissue.
  9. Move the samples to acid- and microwave-safe 15 mL polypropylene centrifuge tubes. Be careful to remove all excess water as any remaining liquid may dilute the nitric acid, and therefore, the oxidizing potential of the acid during tissue degradation.
    NOTE: At this point, tissue may be stored at -20 °C until further analysis. For naturally abundant metals, cleaning the tubes in a 5% nitric acid bath prior to use will ameliorate ambient background levels.

3. Tissue digestion and ICPMS evaluation (Figure 2)

  1. Add approximately 0.25 mL to the 15 mL polypropylene centrifuge tubes for up to 10 larvae (~100 µg) of high-purity nitric acid (69%). Ultrasonicate for 1 h to predigest the samples using the following settings: ultrasonic bath output: 85 W; 42 kHz ± 6%; temperature range: 19-27 °C.
    CAUTION: Wear ear protection during sonication. Nitric acid causes serious respiratory tract, eye, and skin burns. Wear full protective equipment and work in the fume hood or in places with adequate ventilation. It can be flammable with other materials. Nitric acid should be handled exclusively in a fume hood to prevent exposure to vapors produced during digestion. Do not inhale or ingest.
    1. Perform short cycles of tissue digestion (5 min intervals) in an acid-safe microwave digester until all tissue is visibly oxidized (i.e., uniform, clear-yellow solution).
      NOTE: The microwave protocol in Table 1 is recommended to be performed three times and includes a 5 min cooldown interval between each heating step.
    2. Monitor the integrity of the tubes carefully to avoid rupture and conduct short spins in the centrifuge (313 × g for 1 min) between cycles to move acid condensation to the bottom of the tube.
      NOTE: If the tissue is difficult to digest (especially chorions), 30% high-purity hydrogen peroxide can be used after acid digestion. Use the hydrogen peroxide (6.75 mL) to dilute the acid concentration to 3.5%, and allow the samples to sit overnight in a fume hood. Hydrogen peroxide will decompose to H2O and is suitable for ICPMS analysis. Further, alternative metals may dissolve better in hydrochloric acid or a mixture of hydrochloric acid and nitric acid (i.e., aqua regia). Hydrogen peroxide is harmful if swallowed and causes serious eye damage. Wear skin and eye protection22,23.
  2. Once the tissue is visibly oxidized (i.e., uniform, clear-yellow solution), dilute the samples in a fume hood to 3.5% nitric acid using 6.75 mL of high-purity water and vortex to mix thoroughly.
    NOTE: At this point, the samples can be stored at room temperature. This step is unnecessary if hydrogen peroxide was added to aid digestion in step 3.1.
  3. Conduct a matrix-matched, 7-point calibration curve (concentration range of 0.001-10 ppb) using a certified elemental standard (i.e., Pt or Ru, depending on the assay) with the metal of interest and optimal isotope(s) to account for any potential isobaric interferences.
    1. Using a stock concentration of the aqueous, certified elemental standard (Ru, Pt = 1000 ppb), take a 0.1 mL aliquot and pipet into a new 15 mL centrifuge tube. Dilute with 3.5% nitric acid to a final volume of 10 mL to produce a 10 ppb standard solution.
    2. Using the 10 ppb stock, make the following serial dilutions: 0.1, 1.0, and 5.0 ppb standard solutions in 3.5% nitric acid.
    3. Using the 0.1 stock, make the following serial dilutions: 0.001, 0.005, and 0.01 ppb standard solutions in 3.5% nitric acid.
  4. Prepare the ICPMS instrument (see the Table of Materials) for sample analysis as follows:
    1. Prior to starting the instrument, ensure that the Argon gas valve is open, all tubing is securely connected, and clean 5% nitric acid is open for rinsing tubing and glassware between sample analyses.
    2. Check the condition of the torch and cones, and make sure the torch box is securely latched and the spray chamber drainage tube is properly connected to the peripump.
    3. Open the software (see the Table of Materials).
    4. Check the vacuum readings and ensure all turbo pumps are running at 100%.
    5. Click START in the Plasma Control System Status window to initiate the start sequence, turn on the plasma pump, plasma chiller, purge the nebulizer, and light the plasma. Wait for the plasma to be lit and stable when the status window will indicate that the startup sequence is complete. At this point, observe the green dots on the System State window that indicate that all Power supplies are on.
    6. In the menu bar, click on Control | autosampler in the dropdown menu. Enter the autosampler rack position for the tube containing 5% nitric acid. Allow the acid to enter the plasma.
    7. In the menu bar, click on Scans | Magnet in the dropdown menu. In the MagnetScan window, type 115 into the Marker Mass Position and click enter. Allow the magnet to scan across the mass range for 115In (114.6083 to 115.3749) for 30 min while the instrument warms up.
    8. After 30 min, use the autosampler control to move to the position of a 1 ppb multielement tuning solution. Aspirate the tuning solution and tune the instrument to optimize the signal reading. Adjust the torch position (X, Y, Z) such that the torch is aligned with the center of the cones and nebulizer flow rate (~ 30 psi) in the Plasma control window. Make the necessary adjustments in the Ion Optics Tuning window for the Source, Detector, and Analyzer.
    9. Once the signal reading is optimized (~1.2 × 106 counts/s for 1 ppb on 115In), click Stop in the Magnet Scan window.
      1. Click Calibrate Magnet and select Low Resolution in the popup window.
      2. Click OK and open the "Mass Calibration (Low Resolution).smc" file to calibrate the Magnet.
        NOTE: The magnet calibration will measure the counts/s and fit a curve through the following mass range: 7Li to 238U.
      3. Click Save | Use to apply the current magnet calibration to the analyses. If measuring unknown samples with a huge range of concentrations, perform a Detector Calibration to compare ion pulse counts signals at low concentrations to attenuated ion signals produced at higher concentrations. Analyze the samples once tuning and calibration are complete.
    10. In the menu bar, click on Data Acquisition.
      1. Click on Method Setup in the dropdown menu. Use an existing method provided by the manufacturer, or create a method based on the elements of interest. If necessary, adjust the analysis mode, dwell time, switch delay, number of sweeps/cycles, resolution, detection mode, and the park mass for deflector settings.
      2. Click Save to record the method settings. Optimize the parameters for each metal and isotope. See Table 2 for the specific operation parameters used in this study.
    11. In the menu bar, click on Data Acquisition.
      1. Click on Batch Run in the dropdown menu. Alternatively, click on the BATCH Icon below the menu bar. Import the batch parameters from a spreadsheet, or create a sequence in the Batch Run window. Enter the sample type, the autosampler rack position, transfer time, wash time, replicates, sample ID, and method file.
    12. Arrange the batch run in the following order: standard solutions for the calibration curve (0.001-10 ppb Pt or Ru), followed by a quality control standard, then unknown samples.
      NOTE: Standard solutions are measured as counts/s on the ICPMS, and a linear regression is fit through the standards with a relative standard deviation (RSD) > 0.999. Unknowns are also measured as counts/s and solved for concentration in ppb using the linear regression of the calibration curve, y = mx + b. Data processing can also be completed using the referenced software.
    13. Monitor instrument drift and sample reproducibility by including a 0.5 ppb quality control standard every 5-10 samples.
      NOTE: Suitable quality control standards should be a certified standard reference material different from the standard used in the calibration curve.
WattsPowerMinutes
30050%5
30075%5
3000%5
30075%5

Table 1: Microwave digestion protocol for larval tissue mass. Zebrafish larval samples were digested in 0.25 mL of nitric acid. This table has been modified from 24.

Access restricted. Please log in or start a trial to view this content.

Results

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

These results have been previously published24. Tissue uptake studies were conducted with waterborne exposures of cisplatin and a novel Ru-based anticancer compound, PMC79. Lethality and delayed hatching were evaluated for nominal concentrations of cisplatin 0, 3.75, 7.5, 15, 30, and 60 mg/L cisplatin. Pt accumulation in organism tissue was determined by ICPMS analysis, and organism tissue contained respective doses of 0.05, 8.7, 23.5, 59.9, 193.2, and 461.9 ng (Pt) per organism (...

Access restricted. Please log in or start a trial to view this content.

Discussion

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The protocol described here has been implemented to determine the delivery and uptake of metal-based anticancer drugs containing either Pt or Ru. Although these methods have already been published, this protocol discusses important considerations and details to adapt this methodology for a range of compounds. The OECD protocol coupled with tissue digestion and ICPMS analysis allowed us to determine that PMC79 was more potent than cisplatin and resulted in disparate tissue accumulation, suggesting separate mechanisms. Fur...

Access restricted. Please log in or start a trial to view this content.

Disclosures

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

There are no conflicts of interest to be disclosed by any of the authors.

Acknowledgements

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Funding: NJAES-Rutgers NJ01201, NIEHS Training Grant T32-ES 007148, NIH-NIEHS P30 ES005022. Additionally, Brittany Karas is supported by training grant T32NS115700 from NINDS, NIH. The authors acknowledge Andreia Valente and the Portuguese Foundation for Science and Technology (Fundação para a Ciência e Tecnologia, FCT; PTDC/QUI-QIN/28662/2017) for the supply of PMC79.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
AB Strain Zebrafish (Danio reri)Zebrafish International Resource CenterWild-Type ABWild-Type AB Zebrafish
ACS Grade Nitric AcidVWR BDH ChemicalsBDH3130-2.5LPNitric Acid (68-70%); used to make 10% HNO3 acid-bath solution for soaking/pre-celaning centrifuge tubes
Aquatox Fish Diet (Flake)Zeigler Bros, Inc.Flake food to be mixed in a 1:4 ratio of Aquatox Fish Diet to TetraMin Tropical Flakes and used as feed
Artemia cysts, brine shrimpPentairAESBS90Brine shrimp eggs sold in 15-ozz, vacuum-packed cans to be hatched and used as feed
ASX-510 Autosampler for ICPMSTeledyne CETACAutomatic sampler with conifgurable XYZ movement, flowing rinse station, and 0.3 mm inner dimension probe. Compatible with Nu AttoLab software for programmable batch analyses.  
CentrifugeThermo ScientificCL 2Thermo Scientific CL 2 compact benchtop centrifuge with variable speed range up to 5200 rpm; used to bring sample and acid condensate to the bottom of the centrifuge tube bewteen microwave digestion intervals; aids in sample retention
Centrifuge tubesVWR21008-105Ultra high performance polypropylene centrifuge tubes with flat cap; 15 mL volume; leak-proof with conical bottom
Class A Clear Glass Threaded VialsFisherbrand03-339-25BIndividual glass vials for exposure containment
Dimethyl SulfoxideMillipore SigmaD8418Solvent or vehicle for hydrophobic compounds
Fixed Speed Vortex MixerVWR10153-834Vortex mixer; used to homogenize sample after acid digestion and dilution
High Purity Hydrogen PeroxideMerk KGaA, EDM Millipore1.07298.0250Suprapur Hydrogen peroxide (30%); used for sample digestion
High Purity Nitric AcidEDM MilliporeNX0408-2Omni Trace Ultra Nitric Acid (69%); used for sample digestion
Instant Ocean Sea SaltSpectrum Brands, Inc.Instant Ocean® Sea SaltEgg water solution contains instand ocean sea salt with a final concentration of 60 µg/ml
Mars X Microwave Digestion SystemCEM, Matthews, NCMicrowave acid digestion system used to digest and homogenize samples under uniform conditions. For this methodology the open vessel digestion method was completed using single-use polypropylene centrifuge tubes at low power (300 W). 
Multi-element Solution 3SPEX CertiPREPCLMS-3Contains 10 mg/L Au, Hf, Ir, Pd, Pt, Fu, Sb, Sr, Te, Sn in 10% HCl/1% HNO3; used as a quality control standard for Pt and Ru analyses
Nu Instruments AttoM High Resolution Inductively Coupled Plasma Mass Spectrometer (HR-ICP-MS)Nu Instruments/AmatekDouble focussing magnetic sector inductively coupled plasma mass spectrometer with flexible low to high resolution slit system, and dynamic range detector system. Data processing and quantification is done using NuQuant companion software. 
Platinum (Pt) standard solution, NIST 3140National Institute of Standards and Technology3140Prepared from ampoule containing 9.996 mg/g Pt in 10% HCl; ; used as a quality control standard for Pt analyses
Platinum (Pt) standard solution, single-elementHigh Purity Standards100040-2Contains 1000 mg/L Pt in 5% HCl
Ruthenium (Ru) standard solution, single-elementHigh Purity Standards100046-2Contains 1000 mg/L Ru in 2% HCl
TetraMin Tropical FlakesTetra77101Flake food to be mixed in a 1:4 ratio of Aquatox Fish Diet to TetraMin Tropical Flakes and used as feed
Trace Metal Grade Nitric AcidVWR BDH Chemicals87003-261Aristar Plus Nitric Acid (67-70%); used for rinse solution in ASX-510 Autosampler
Ultrasonic water bathVWRB2500A-DTHUltrasonic water bath used to aid in acid digestion prior to microwave digestion

References

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Rehman, K., Fatima, F., Waheed, I., Akash, M. S. H. Prevalence of exposure of heavy metals and their impact on health consequences. Journal of Cellular Biochemistry. 119 (1), 157-184 (2018).
  2. Anyanwu, B. O., Ezejiofor, A. N., Igweze, Z. N., Orisakwe, O. E. Heavy metal mixture exposure and effects in developing nations: an update. Toxics. 6 (4), 65(2018).
  3. Doherty, C. L., Buckley, B. T. Translating analytical techniques in geochemistry to environmental health. Molecules. 26 (9), 2821(2021).
  4. Boros, E., Dyson, P. J., Gasser, G. Classification of metal-based drugs according to their mechanisms of action. Chem. 6 (1), 41-60 (2020).
  5. Robertson, J., Barr, R., Shulman, L. N., Forte, G. B., Magrini, N. Essential medicines for cancer: WHO recommendations and national priorities. Bulletin of the World Health Organization. 94 (10), 735-742 (2016).
  6. Wheate, N. J., Walker, S., Craig, G. E., Oun, R. The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Transactions. 39 (35), 8113-8127 (2010).
  7. Brown, A., Kumar, S., Tchounwou, P. B. Cisplatin-based chemotherapy of human cancers. Journal of Cancer Science & Therapy. 11 (4), 97(2019).
  8. Ghosh, S. Cisplatin: The first metal based anticancer drug. Bioorganic Chem. 88, 102925(2019).
  9. Abid, M., Shamsi, F., Azam, A. Ruthenium complexes: an emerging ground to the development of metallopharmaceuticals for cancer therapy. Mini Reviews in Medicinal Chemistry. 16 (10), 772-786 (2016).
  10. Alessio, E., Messori, L. NAMI-A and KP1019/1339, two iconic ruthenium anticancer drug candidates face-to-face: a case story in medicinal inorganic chemistry. Molecules. 24 (10), 1995(2019).
  11. Alessio, E., Mestroni, G., Bergamo, A., Sava, G. Ruthenium antimetastatic agents. Current Topics in Medicinal Chemistry. 4 (15), 1525-1535 (2004).
  12. Lin, K., Zhao, Z. -Z., Bo, H. -B., Hao, X. -J., Wang, J. -Q. Applications of ruthenium complex in tumor diagnosis and therapy. Frontiers in Pharmacology. 9, 1323(2018).
  13. Howe, K., et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 496 (7446), 498-503 (2013).
  14. Wiley, D. S., Redfield, S. E., Zon, L. I. Chemical screening in zebrafish for novel biological and therapeutic discovery. Methods in Cell Biology. 138, 651-679 (2017).
  15. Bambino, K., Chu, J. Zebrafish in toxicology and environmental health. Current Topics in Developmental Biology. 124, 331-367 (2017).
  16. Rubinstein, A. L. Zebrafish assays for drug toxicity screening. Expert Opinion on Drug Metabolism & Toxicology. 2 (2), 231-240 (2006).
  17. Cassar, S., et al. Use of zebrafish in drug discovery toxicology. Chemical Research in Toxicology. 33 (1), 95-118 (2020).
  18. Westerfield, M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio). 4th edition. , University of Oregon Press. Eugene. (2000).
  19. Pfizer. Material safety data sheet: cisplatin injection). Pfizer. , Available from: https://cdn.pfizer.com/pfizercom/products/material_safety_data/PZ01470.pdf (2011).
  20. Nasiadka, A., Clark, M. D. Zebrafish breeding in the laboratory environment. ILAR Journal. 53 (2), 161-168 (2012).
  21. OECD. Test No. 236: Fish embryo acute toxicity (FET) test. OECD Guidelines for the Testing of Chemicals. , Available from: https://www.oecd-ilibrary.org/environment/test-no-236-fish-embryo-acute-toxicity-fet-test_9789264203709-en (2013).
  22. EMD Millipore Corporation. Material Safety Data Sheet: OmniTrace Nitric Acid. EMD Millipore Corporation. , (2013).
  23. Safety data sheet: Hydrogen peroxide 30% Suprapur. EMD Millipore Corporation. , Available from: https://www.merckmillipore.com/IN/en/product/Hydrogen-peroxide-300-0,MDA_CHEM-107298 (2014).
  24. Karas, B. F., et al. A novel screening method for transition metal-based anticancer compounds using zebrafish embryo-larval assay and inductively coupled plasma-mass spectrometry analysis. Journal of Applied Toxicology. 39 (8), 1173-1180 (2019).
  25. Henn, K., Braunbeck, T. Dechorionation as a tool to improve the fish embryo toxicity test (FET) with the zebrafish (Danio rerio). Comparative Biochemistry and Physiology. Toxicology & Pharmacology: CBP. 153 (1), 91-98 (2011).
  26. Mandrell, D., et al. Automated zebrafish chorion removal and single embryo placement: optimizing throughput of zebrafish developmental toxicity screens. Journal of Laboratory Automation. 17 (1), 66-74 (2012).
  27. Karas, B. F., Hotz, J. M., Buckley, B. T., Cooper, K. R. Cisplatin alkylating activity in zebrafish causes resistance to chorionic degradation and inhibition of osteogenesis. Aquatic Toxicology. 229, 105656(2020).

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Zebrafish ToxicokineticsMetal Dose QuantificationPlatinum UptakeRuthenium UptakeWaterborne ExposureTissue DigestionICPMS AnalysisLarval Tissue UptakeChemotherapeutic Metals

Related Articles